Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Implementing ecopharmacovigilance in practice: challenges and potential opportunities.

Holm G, Snape JR, Murray-Smith R, Talbot J, Taylor D, Sörme P.

Drug Saf. 2013 Jul;36(7):533-46. doi: 10.1007/s40264-013-0049-3.

2.

Ecopharmacovigilance: Current state, challenges, and opportunities in China.

Wang J, Hu X.

Indian J Pharmacol. 2014 Jan-Feb;46(1):13-7. doi: 10.4103/0253-7613.125158.

3.

Implementing ecopharmacovigilance (EPV) from a pharmacy perspective: A focus on non-steroidal anti-inflammatory drugs.

Wang J, He B, Yan D, Hu X.

Sci Total Environ. 2017 Dec 15;603-604:772-784. doi: 10.1016/j.scitotenv.2017.02.209. Epub 2017 Apr 6. Review.

PMID:
28390750
4.

Knowledge, perceptions, and practice of ecopharmacovigilance among pharmacy professionals in China.

Liu J, Wang J, Hu XM.

Environ Monit Assess. 2017 Oct 11;189(11):552. doi: 10.1007/s10661-017-6289-4.

PMID:
29022189
5.

Eco-pharmacovigilance of non-steroidal anti-inflammatory drugs: Necessity and opportunities.

He BS, Wang J, Liu J, Hu XM.

Chemosphere. 2017 Aug;181:178-189. doi: 10.1016/j.chemosphere.2017.04.084. Epub 2017 Apr 21. Review.

PMID:
28437743
6.

Sources, pathways, and relative risks of contaminants in surface water and groundwater: a perspective prepared for the Walkerton inquiry.

Ritter L, Solomon K, Sibley P, Hall K, Keen P, Mattu G, Linton B.

J Toxicol Environ Health A. 2002 Jan 11;65(1):1-142. Review.

PMID:
11809004
7.

Targeted eco-pharmacovigilance for ketoprofen in the environment: Need, strategy and challenge.

Wang J, Zhao SQ, Zhang MY, He BS.

Chemosphere. 2018 Mar;194:450-462. doi: 10.1016/j.chemosphere.2017.12.020. Epub 2017 Dec 6. Review.

PMID:
29227893
8.

Human-use antibacterial residues in the natural environment of China: implication for ecopharmacovigilance.

Wang J, He B, Hu X.

Environ Monit Assess. 2015 Jun;187(6):331. doi: 10.1007/s10661-015-4514-6. Epub 2015 May 7.

PMID:
25947893
9.

Environmental impact assessment and control of pharmaceuticals: the role of environmental agencies.

Adler NE, Koschorreck J, Rechenberg B.

Water Sci Technol. 2008;57(1):91-7. doi: 10.2166/wst.2008.816.

PMID:
18192745
10.

Detection and drivers of exposure and effects of pharmaceuticals in higher vertebrates.

Shore RF, Taggart MA, Smits J, Mateo R, Richards NL, Fryday S.

Philos Trans R Soc Lond B Biol Sci. 2014 Nov 19;369(1656). pii: 20130570. doi: 10.1098/rstb.2013.0570. Review.

11.

Risk management frameworks for human health and environmental risks.

Jardine C, Hrudey S, Shortreed J, Craig L, Krewski D, Furgal C, McColl S.

J Toxicol Environ Health B Crit Rev. 2003 Nov-Dec;6(6):569-720. Review.

PMID:
14698953
12.

A ranking of European veterinary medicines based on environmental risks.

Kools SA, Boxall A, Moltmann JF, Bryning G, Koschorreck J, Knacker T.

Integr Environ Assess Manag. 2008 Oct;4(4):399-408. doi: 10.1897/IEAM_2008-002.1.

PMID:
18563959
13.

Part 5. Public health and air pollution in Asia (PAPA): a combined analysis of four studies of air pollution and mortality.

Wong CM, Vichit-Vadakan N, Vajanapoom N, Ostro B, Thach TQ, Chau PY, Chan EK, Chung RY, Ou CQ, Yang L, Peiris JS, Thomas GN, Lam TH, Wong TW, Hedley AJ, Kan H, Chen B, Zhao N, London SJ, Song G, Chen G, Zhang Y, Jiang L, Qian Z, He Q, Lin HM, Kong L, Zhou D, Liang S, Zhu Z, Liao D, Liu W, Bentley CM, Dan J, Wang B, Yang N, Xu S, Gong J, Wei H, Sun H, Qin Z; HEI Health Review Committee.

Res Rep Health Eff Inst. 2010 Nov;(154):377-418.

PMID:
21446215
14.

Pharmaceuticals in the environment: scientific evidence of risks and its regulation.

Küster A, Adler N.

Philos Trans R Soc Lond B Biol Sci. 2014 Nov 19;369(1656). pii: 20130587. doi: 10.1098/rstb.2013.0587.

15.

The fish embryo toxicity test as an animal alternative method in hazard and risk assessment and scientific research.

Embry MR, Belanger SE, Braunbeck TA, Galay-Burgos M, Halder M, Hinton DE, Léonard MA, Lillicrap A, Norberg-King T, Whale G.

Aquat Toxicol. 2010 Apr 15;97(2):79-87. doi: 10.1016/j.aquatox.2009.12.008. Epub 2009 Dec 16. Review.

PMID:
20061034
16.

[The new pharmacovigilance legislation in practice].

Broekmans AW, Mol PG.

Ned Tijdschr Geneeskd. 2014;158:A7129. Dutch.

PMID:
24846112
17.

Environmental risk assessment of veterinary medicinal products in the EU--a regulatory perspective.

Koschorreck J, Koch C, Rönnefahrt I.

Toxicol Lett. 2002 May 10;131(1-2):117-24. Review.

PMID:
11988364
18.

Chemicals of emerging concern in the Great Lakes Basin: an analysis of environmental exposures.

Klecka G, Persoon C, Currie R.

Rev Environ Contam Toxicol. 2010;207:1-93. doi: 10.1007/978-1-4419-6406-9_1. Review.

PMID:
20652664
19.

Predicting future human and environmental health challenges: the Health and Environmental Sciences Institute's scientific mapping exercise.

Smith LL, Brent RL, Cohen SM, Doerrer NG, Goodman JI, Greim H, Holsapple MP, Lightfoot RM.

Crit Rev Toxicol. 2008;38(10):817-45. doi: 10.1080/10408440802486378 . Review.

PMID:
18853291
20.

The EPA's human exposure research program for assessing cumulative risk in communities.

Zartarian VG, Schultz BD.

J Expo Sci Environ Epidemiol. 2010 Jun;20(4):351-8. doi: 10.1038/jes.2009.20. Epub 2009 Apr 15.

Supplemental Content

Support Center